Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)

SHE:301408 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	-	957.97	1,002	1,336	482.1	284.51
Trading Asset Securities	-	22	10	12.41	-	0.5
Cash & Short-Term Investments	999.07	979.97	1,012	1,349	482.1	285.01
Cash Growth	17.73%	-3.13%	-24.99%	179.76%	69.16%	23.37%
Accounts Receivable	-	588.83	472.6	513.14	470.77	294.32
Other Receivables	-	9.6	8.81	36.24	34.52	30.82
Receivables	-	598.43	481.42	549.38	505.29	325.14
Inventory	-	1,055	863.84	772.09	545.01	436.19
Prepaid Expenses	-	13.55	15.63	8.27	2.52	4.22
Other Current Assets	-	266.34	224.87	147.78	165.22	62.74
Total Current Assets	-	2,913	2,597	2,826	1,700	1,113
Property, Plant & Equipment	-	985	967.8	870.15	533.42	542.53
Long-Term Investments	-	45.52	82.2	92.81	25.45	8.92
Goodwill	-	1,282	988.37	609.31	190.06	190.06
Other Intangible Assets	-	63.9	67.21	62.51	33	8.26
Long-Term Deferred Tax Assets	-	51.78	40.65	32.83	21.92	15.17
Long-Term Deferred Charges	-	82.96	59.03	52.11	58.97	92.32
Other Long-Term Assets	-	63.84	25.48	65.74	13.23	0.5
Total Assets	-	5,488	4,828	4,612	2,576	1,971

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	-	1,666	1,158	1,027	698.74	468.23
Accrued Expenses	-	174.24	140.25	99.84	101.68	79.98
Short-Term Debt	-	345.3	316.92	513.51	340.31	150.77
Current Portion of Long-Term Debt	-	179.36	116.02	10.25	-	-
Current Portion of Leases	-	199.71	210.44	193.64	154.24	144
Current Income Taxes Payable	-	38.14	20.63	12.3	34.63	13.15
Current Unearned Revenue	-	42.86	37.11	27.06	19.41	11.25
Other Current Liabilities	-	39.74	178.94	80.31	12.7	15.25
Total Current Liabilities	-	2,686	2,179	1,964	1,362	882.64
Long-Term Debt	-	407.08	358.83	331.15	18.95	-
Long-Term Leases	-	220.08	222.85	237.65	248.51	303.03
Long-Term Unearned Revenue	-	1.81	0.81	0.91	-	-
Long-Term Deferred Tax Liabilities	-	6.2	6.65	6.32	-	-
Other Long-Term Liabilities	-	4.5	-	95.4	-	0.33
Total Liabilities	-	3,325	2,768	2,635	1,629	1,186

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	-	400.01	400.01	400.01	340	340
Additional Paid-In Capital	-	916.8	977.86	1,014	194.7	192.99
Retained Earnings	-	780.17	627.42	529.39	412.58	251.81
Total Common Equity	2,176	2,097	2,005	1,944	947.28	784.8
Minority Interest	-	66.13	55.14	33	-0.27	0.25
Shareholders' Equity	2,244	2,163	2,060	1,977	947.01	785.05
Total Liabilities & Equity	-	5,488	4,828	4,612	2,576	1,971

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	1,271	1,352	1,225	1,286	762.02	597.8
Net Cash (Debt)	-271.83	-371.57	-213.43	62.53	-279.92	-312.8
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.68	-0.93	-0.53	0.16	-0.82	-0.94
Filing Date Shares Outstanding	400.02	400.01	400.01	400.01	340	340
Total Common Shares Outstanding	400.02	400.01	400.01	400.01	340	340
Working Capital	-	227.37	418.84	862.52	338.42	230.65
Book Value Per Share	5.44	5.24	5.01	4.86	2.79	2.31
Tangible Book Value	830.76	750.67	949.71	1,272	724.22	586.49
Tangible Book Value Per Share	2.08	1.88	2.37	3.18	2.13	1.72
Buildings	-	382.39	219.2	238.73	23.15	23.15
Machinery	-	337.07	297.24	270.16	79.38	65.74
Construction In Progress	-	34.73	168.66	61.34	32.24	0.25

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error